BioNTech SE logo BNTX - BioNTech SE

Price: -- -- | CONSENSUS: Buy DETAILS
STRONG
BUY
0
BUY 21
HOLD 3
SELL 0
STRONG
SELL
0
| PRICE TARGET: $130.25 DETAILS
HIGH: $158.00
LOW: $96.00
MEDIAN: $131.50
CONSENSUS: $130.25
UPSIDE: 40.89%
Metric 2025 2024 2023 2022 2021 2020 2019 2018 2017
Revenue
Revenue 2,756.6 2,751.1 3,819 17,310.6 18,976.7 482.3 108.6 127.6 61.6
Cost of Revenue 616.5 541.3 599.8 2,995 2,911.5 59.3 17.4 13.7 9.3
Gross Profit 2,140.2 2,209.8 3,219.2 14,315.6 16,065.2 423 91.2 113.9 52.3
Operating Expenses
R&D Expenses 2,021.8 2,254.2 1,783.1 1,537 949.2 645 226.5 143.1 85.5
SG&A Expenses 698.2 599 557.7 541.2 327.2 108.5 43.3 27.1 29.5
Other Expenses 44.0 670.9 188 (405.3) (495) (248.1) 2.9 (2.4) (1.4)
Operating Expenses 2,764.0 3,524.1 2,528.8 1,672.9 781.4 505.4 272.7 167.7 113.6
Operating Income
Operating Income (623.9) (1,314.3) 690.4 12,642.7 15,283.8 (82.4) (181.5) (53.9) (61.3)
Interest Expense 13.6 13.2 7.8 15.8 5.6 1.9 1.7 1.8 0.7
Interest Income 252.2 0 351.3 47.4 1.6 1.5 1.8 2.1 2.1
Profitability
EBITDA (628.0) (367.1) 1,377.4 13,096.3 15,002.3 (105.1) (143.8) (24.0) (74.7)
EBIT (995.7) (665.1) 1,194 12,973 14,927.1 (143.8) (177.7) (45.9) (85.2)
Income Before Tax (1,009.3) (677.7) 1,186.1 12,954.1 15,046.4 (145.8) (179.4) (47.7) (85.9)
Income Tax Expense 81.9 (12.4) 255.8 3,519.7 4,753.9 (161) (0.2) 0.6 0.0
Net Income (1,091.3) (665.3) 930.3 9,434.4 10,292.5 15.2 (179.1) (48.0) (85.7)
Per Share Data
EPS (Basic) -4.51 -2.77 3.87 38.08 43.87 0.06 -0.85 -0.21 -0.38
EPS (Diluted) -4.51 -2.77 3.83 37.09 41.21 0.06 -0.85 -0.21 -0.38
Shares Outstanding 241.7 240.4 240.6 243.3 244 235.4 211.5 226.9 226.9
Metric 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016
Current Assets
Cash & Cash Equivalents 7,672.1 9,761.9 11,663.7 13,875.1 1,692.7 1,210.2 519.1 411.5 172.1 303.7
Short-Term Investments 7,161.8 7,021.7 4,885.3 189.4 381.6 137.2 1.7 0.3 0.2 1.5
Net Receivables 984.5 1,523.9 2,339.7 7,146 12,382.1 165.5 11.9 28.4 4.6 6.0
Inventory 110.7 283.3 357.7 439.6 502.5 64.1 12.1 5.8 3.9 3.3
Other Current Assets 210.7 212.7 280.9 271.9 113.4 89.9 15.3 12.2 8.8 2.8
Total Current Assets 16,139.7 18,803.5 19,527.3 21,922 15,072.3 1,666.9 560.2 449.0 189.6 318.1
Non-Current Assets
Property, Plant & Equipment 1,290.6 1,183.4 971.6 821.1 520.4 326 148.1 116.0 101.5 60.5
Goodwill 367.7 380.6 362.5 61.2 57.8 53.7 3.0 0.5 0.5 0.5
Intangible Assets 1,605.3 790.4 804.1 158.5 144.6 103.8 84.1 87.5 83.0 10.7
Long-Term Investments 2,485.4 1,254 1,176.1 80.2 21.3 0 0 0.0 0.0 0.1
Other Non-Current Assets 77.0 36.1 83.4 6.5 14.4 168.2 2.4 (0.0) (0.0) 0.1
Total Non-Current Assets 5,839.5 3,726.2 3,479 1,357.1 758.5 651.7 237.5 204.0 185.1 71.8
Total Assets 21,979.2 22,529.7 23,006.3 23,279.1 15,830.8 2,318.6 797.6 653.0 374.7 390.0
Current Liabilities
Account Payables 534.7 426.7 354 204.1 160 102.3 20.5 41.7 52.5 6.2
Short-Term Debt 52.2 39.5 28.1 36 129.9 3 1.8 0 0 0
Deferred Revenue 754.6 294.9 353.3 77.1 186.1 0 0 66.0 77.3 33.5
Other Current Liabilities 734.4 1,757.6 809.6 2,037.5 1,436.7 494.6 105.6 79.2 86.7 17.0
Total Current Liabilities 2,141.4 2,523.2 2,070.5 2,950.6 3,481.6 606 138.1 126.1 158.5 56.6
Non-Current Liabilities
Long-Term Debt 29.9 214.7 191 176.2 171.6 152.9 14.8 0 0 0
Deferred Tax Liabilities 84.3 42.4 39.7 6.2 66.7 0 0 (205.6) (214.0) 0
Other Non-Current Liabilities 234.5 155.3 60.7 42.1 208.2 109.8 97.1 0 214.0 28.1
Total Non-Current Liabilities 621.8 595.4 689.9 272.9 455.5 340.8 166.0 259.9 264.4 301.5
Total Liabilities 2,763.2 3,118.6 2,760.4 3,223.5 3,937.1 946.8 304.2 386.0 422.9 358.1
Stockholders' Equity
Common Stock 258.9 248.6 248.6 248.6 246.3 246.3 232.3 193.3 166.8 3.3
Retained Earnings 17,954.3 19,098 19,763.3 18,833 9,882.9 (409.6) (424.8) (245.8) (197.8) (112.1)
Accumulated Other Comprehensive Income (1,461.7) (1,325.5) (984.6) (848.9) 93.9 1,539.9 691.5 318.6 (18.3) 139.3
Total Stockholders' Equity 19,216.0 19,411.1 20,245.9 20,055.6 11,893.7 1,371.8 493.5 266.2 (49.3) 30.5
Total Liabilities & Equity 21,979.2 22,529.7 23,006.3 23,279.1 15,830.8 2,318.6 797.6 653.0 374.7 390.0
Debt Metrics
Total Debt 267.3 254.2 219.1 212.2 301.5 240.1 74.2 54.2 50.3 26.7
Net Debt (7,404.8) (9,507.7) (11,444.6) (13,662.9) (1,391.2) (970.1) (444.9) (357.3) (121.8) (277.0)
Metric 2025 2024 2023 2022 2021 2020 2019 2018 2017
Operating Activities
Net Income (1,091.3) (677.7) 1,186.1 12,954.1 15,046.4 (145.8) (179.4) (47.7) (85.9)
Depreciation & Amortization 367.7 298 183.4 123.3 75.2 38.7 33.9 22.0 10.5
Stock-Based Compensation 0 100.9 51.4 108.6 93.9 32.1 30.2 7.6 5.9
Change in Working Capital 516.6 1,220.6 5,574.8 4,518.5 (10,730.4) (93.1) (83.5) (41.0) (8.0)
Other Non-Cash Items 574.0 (734.1) (1,624.3) (4,127.1) (3,595.4) 154.6 0.3 (0.2) (1.4)
Operating Cash Flow 438.0 207.7 5,371.4 13,577.4 889.7 (13.5) (198.5) (58.2) (52.6)
Investing Activities
Capital Expenditure (168.2) (452.3) (705.5) (363.3) (154) (85.4) (71.1) (67.9) (57.7)
Acquisitions 183.3 0 (336.9) 0 (20.8) (60.6) (6.1) 0.7 4.9
Purchases of Investments (10,971.7) (12,370.3) (6,982.3) (47.8) (394.7) 0 0 0 0
Sales/Maturities of Investments 9,136.8 10,740.2 1,191.4 375.2 0 0 0 0 0
Other Investing Activities 0 (164.6) (576.6) (33.5) (23.1) (18.2) (32.5) 0.7 5.2
Investing Cash Flow (2,371.1) (2,081.2) (6,954.5) (35.3) (566.1) (144.8) (77.2) (67.1) (52.5)
Financing Activities
Net Debt Issuance (10.9) (45.9) (40.1) (59.1) (66.7) 141.7 7.9 3.5 (1.6)
Stock Repurchased 0 0 (738.5) (986.4) 0 0 0 0 0
Dividends Paid 0 0 0 (484.3) 0 0 0 0 0
Other Financing Activities (40.0) 0 0 0 0 0 0 0 0
Financing Cash Flow (50.8) (45.9) (778.6) (1,419.3) 94.2 894.7 383.3 365.2 (1.6)
Cash Position
Net Change in Cash (931.2) (1,901.8) (2,211.4) 12,182.4 482.5 691.1 107.6 239.4 (131.6)
Cash at Beginning 8,603.3 11,663.7 13,875.1 1,692.7 1,210.2 519.1 411.5 172.1 303.7
Cash at End 7,672.1 9,761.9 11,663.7 13,875.1 1,692.7 1,210.2 519.1 411.5 172.1
Free Cash Flow 269.8 (244.6) 4,665.9 13,214.1 735.7 (98.9) (269.6) (126.0) (110.3)
Key Metrics 2025 2024 2023 2022 2021 2020 2019 2018 2017
Income Statement
Revenue 2,756.6 2,751.1 3,819 17,310.6 18,976.7 482.3 108.6 127.6 61.6
Gross Profit 2,140.2 2,209.8 3,219.2 14,315.6 16,065.2 423 91.2 113.9 52.3
Operating Income (623.9) (1,314.3) 690.4 12,642.7 15,283.8 (82.4) (181.5) (53.9) (61.3)
Net Income (1,091.3) (665.3) 930.3 9,434.4 10,292.5 15.2 (179.1) (48.0) (85.7)
EPS (Diluted) -4.51 -2.77 3.83 37.09 41.21 0.06 -0.85 -0.21 -0.38
Balance Sheet
Cash & Equivalents 7,672.1 9,761.9 11,663.7 13,875.1 1,692.7 1,210.2 519.1 411.5 172.1 303.7
Total Assets 21,979.2 22,529.7 23,006.3 23,279.1 15,830.8 2,318.6 797.6 653.0 374.7 390.0
Total Debt 267.3 254.2 219.1 212.2 301.5 240.1 74.2 54.2 50.3 26.7
Stockholders' Equity 19,216.0 19,411.1 20,245.9 20,055.6 11,893.7 1,371.8 493.5 266.2 (49.3) 30.5
Cash Flow
Operating Cash Flow 438.0 207.7 5,371.4 13,577.4 889.7 (13.5) (198.5) (58.2) (52.6)
Capital Expenditure (168.2) (452.3) (705.5) (363.3) (154) (85.4) (71.1) (67.9) (57.7)
Free Cash Flow 269.8 (244.6) 4,665.9 13,214.1 735.7 (98.9) (269.6) (126.0) (110.3)